Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
33.63
+0.43 (1.30%)
Jun 13, 2025, 2:42 PM - Market open
Cytokinetics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$70.92
Upside
+110.88%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $71 → $53 | Buy | Maintains | $71 → $53 | +57.60% | Jun 9, 2025 |
| Mizuho | Mizuho | Buy Maintains $103 → $84 | Buy | Maintains | $103 → $84 | +149.78% | May 29, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +114.09% | May 14, 2025 |
| Barclays | Barclays | Buy Maintains $55 → $53 | Buy | Maintains | $55 → $53 | +57.60% | May 8, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $82 → $80 | Buy | Maintains | $82 → $80 | +137.88% | May 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $86 → $80 | Strong Buy | Maintains | $86 → $80 | +137.88% | May 7, 2025 |
| UBS | UBS | Hold Maintains $47 → $41 | Hold | Maintains | $47 → $41 | +21.91% | May 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +114.09% | May 2, 2025 |
| Barclays | Barclays | Buy Initiates $55 | Buy | Initiates | $55 | +63.54% | Apr 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +256.82% | Apr 21, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $62 → $54 | Hold | Maintains | $62 → $54 | +60.57% | Apr 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +256.82% | Apr 15, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $78 | Buy | Reiterates | $78 | +131.94% | Apr 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +114.09% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +256.82% | Apr 4, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $78 | Buy | Reiterates | $78 | +131.94% | Apr 3, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.